AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimigen-MV1 Tablet

Prescription Icon
Prescription Required

Marketer

Ekard Life Sciences Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glimigen-MV1 Tablet

DiaBeta-Duo is an antidiabetic medication, a combination drug for managing type 2 diabetes in adults. It regulates blood glucose levels. DiaBeta-Duo tablets should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood glucose response. Continued use is crucial, even with controlled blood sugar; abrupt cessation can elevate glucose levels, risking kidney complications, vision loss, neuropathy, and limb impairment. DiaBeta-Duo is one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight control as recommended by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Carry a fast-acting glucose source (e.g., sugary snacks, fruit juice) to counteract this. Alcohol increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. DiaBeta-Duo is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring is essential, along with potential blood tests to track blood cell counts and liver function.

Uses of Glimigen-MV1 Tablet

Managing type 2 diabetes

Major Benefits of Glimigen-MV1 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimigen-MV1 Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

Common Side effects of Glimigen-MV1 Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimigen-MV1 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimigen-MV1 Tablet whole; do not crush, chew, or break it. Administer on an empty stomach.

How Glimigen-MV1 Tablet works:

Tri-action Glimigen-MV1 tablets contain a blend of three antidiabetic medications.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glimigen-MV1 Tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimigen-MV1 Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glimigen-MV1 Tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

Employing Glimigen-MV1 Tablets in individuals with kidney impairment carries a significant risk and should be avoided. Seek medical advice before use. The use of Glimigen-MV1 Tablets is contraindicated in patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Glimigen-MV1 Tablets cautiously, potentially requiring dose modification. Consult a physician. A low initial dose is generally recommended for those with mild to moderate liver disease; its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimigen-MV1 Tablet :

Should you forget a Glimigen-MV1 Tablet dose, ingest it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimigen-MV1 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimigen-MV1 Tablet

Glimigen-MV1 Tablet combines glimepiride, metformin, and voglibose to treat type 2 diabetes mellitus in adults. It improves blood glucose control when used with diet and exercise. Glimepiride boosts insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This combination is unsuitable for type 1 diabetes.
Glimigen-MV1 Tablet may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste, flatulence, stomach pain, headache, rash, and respiratory infection.
Glimigen-MV1 Tablets are contraindicated in patients with known allergies to any constituent or excipient. This medication should also be avoided in those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Glimigen-MV1 Tablets and alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Glimigen-MV1 Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimigen-MV1 Tablet
78
MRP 95
17% off